Paid Clinical Trials Alaska
Discover 31 paid clinical trials in Alaska. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Rilvegostomig & Fluoropyrimidine & Trastuzumab DeruxtecanA Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Sponsor:
AstraZeneca
Location:
Code:
NCT06764875
Conditions
HER2-positive Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rilvegostomig
Trastuzumab deruxtecan
Trastuzumab
Pembrolizumab
5-fluorouracil
HEPA PurifiersThe Clean Air Study: HEPA Purifiers to Improve Indoor Air Quality and Health in Rural Alaska Homes
Sponsor:
Alaska Native Tribal Health Consortium
Location:
Code:
NCT06534385
Conditions
Air Pollution, Indoor
Eligibility Criteria
Sex: All
Age: 0 - 5
Healthy Volunteers: Accepted
Interventions
Air purifier
ZongertinibBeamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Sponsor:
Boehringer Ingelheim
Location:
Code:
NCT06581432
Conditions
Solid Tumours
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Zongertinib
ZN-c3A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
Sponsor:
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Location:
Code:
NCT04814108
Conditions
Uterine Serous Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ZN-c3
Metabolism-Informed CareMetabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)
Sponsor:
Southcentral Foundation
Location:
Code:
NCT06556238
Conditions
Smoking Cessation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nicotine Metabolite Ratio
Molecular Residual DiseaseEXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Sponsor:
Exact Sciences Corporation
Location:
Code:
NCT06401421
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ctDNA MRD test
Observational StudySchool Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Alaska
Sponsor:
University of Arkansas
Location:
Code:
NCT05593484
Conditions
Hearing Loss
Eligibility Criteria
Sex: All
Age: 3 - 21
Healthy Volunteers: Accepted
Interventions
Standard Referral
Specialty Telemedicine Access for Referrals (STAR)
Golcadomide & RituximabA Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Sponsor:
Celgene
Location:
Code:
NCT06425302
Conditions
Lymphoma, Follicular
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Golcadomide
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine
RAINBO BLUE & TAPERAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT05640999
Conditions
Endometrial Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Vaginal brachytherapy
Adjuvant radiotherapy (EBRT +/- brachytherapy)
Observation
BCG & ALT-803A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Sponsor:
ImmunityBio, Inc.
Location:
Code:
NCT02138734
Conditions
Non-muscle Invasive Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BCG+N-803( 50mg BCG/ Instillation+ N-803( 400 μg/instillation). )
BCG( 50mg/Instillation)